J. Neaton

Most-cited papers

1. Remdesivir for the Treatment of Covid-19 — Final Report

   J. Beigel, Kay M. Tomashek, L. Dodd, A. Mehta +36 more

   2020New England Journal of Medicine5,574 citations Open access

   Semantic Scholar

   Save

2. Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection

   J. Lundgren, A. Babiker, F. Gordin, S. Emery +15 more

   2015New England Journal of Medicine2,591 citations Open access

   Semantic Scholar

   Save

3. A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection

   R. Davey, Lori E. Dodd, M. Proschan, J. Neaton +9 more

   2016New England Journal of Medicine432 citations Open access

   Semantic Scholar

   Save

4. A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19

   J. Lundgren, B. Grund, C. Barkauskas, T. Holland +42 more

   2020New England Journal of Medicine347 citations Open access

   Semantic Scholar

   Save

5. Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease

   F. Zannad, S. Anker, William M. Byra, J. Cleland +9 more

   2018New England Journal of Medicine304 citations Open access

   Semantic Scholar

   Save

6. Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in Liberia

   S. Kennedy, F. Bolay, M. Kieh, G. Grandits +22 more

   2017New England Journal of Medicine216 citations Open access

   Semantic Scholar

   Save

7. Sex-specific relevance of diabetes to occlusive vascular and other mortality: a collaborative meta-analysis of individual data from 980 793 adults from 68 prospective studies

   L. Gnatiuc, W. Herrington, J. Halsey, J. Tuomilehto +168 more

   2018The Lancet Diabetes and Endocrinology190 citations Open access

   Semantic Scholar

   Save

8. Relevance of Interleukin-6 and D-Dimer for Serious Non-AIDS Morbidity and Death among HIV-Positive Adults on Suppressive Antiretroviral Therapy

   B. Grund, J. Baker, S. Deeks, Julian A. Wolfson +6 more

   2016PLoS ONE182 citations Open access

   Semantic Scholar

   Save

9. A Longitudinal Study of Ebola Sequelae in Liberia

   M. Sneller, Cavan Reilly, Moses Badio, R. Bishop +14 more

   2019New England Journal of Medicine162 citations Open access

   Semantic Scholar

   Save

10. Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial

    Wesley H. Uriel Cavan S. David M. Robert L. Michael Kevin Self Sandkovsky Reilly Vock Gottlieb Mack Golden D, W. Self, U. Sandkovsky, Cavan Reilly +496 more

    2021Lancet. Infectious Diseases (Print)156 citations Open access

    Semantic Scholar

    Save

11. Interleukin 6 Is a Stronger Predictor of Clinical Events Than High-Sensitivity C-Reactive Protein or D-Dimer During HIV Infection.

    Á. Borges, Jemma L. O'Connor, A. Phillips, J. Neaton +6 more

    2016Journal of Infectious Diseases129 citations Open access

    Semantic Scholar

    Save

12. Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial

    Richard T. Davey, Eduardo Fernández-Cruz, Norman Markowitz, S. Pett +149 more

    2019The Lancet Respiratory Medicine108 citations Open access

    Semantic Scholar

    Save

13. Effect estimates in randomized trials and observational studies: comparing apples with apples.

    S. Lodi, A. Phillips, J. Lundgren, R. Logan +26 more

    2019American Journal of Epidemiology105 citations Open access

    Semantic Scholar

    Save

14. Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial

    Thomas L. Adit A. Roger Thomas A. Nicole Greg Andrew Noel Holland Ginde Paredes Murray Engen Grandits Vekste, T. Holland, A. Ginde, R. Paredes +100 more

    2022The Lancet Respiratory Medicine89 citations Open access

    Semantic Scholar

    Save

15. Letter by Kuller and Neaton Regarding Article, “Association of Race With Mortality and Cardiovascular Events in a Large Cohort of US Veterans”

    L. Kuller, J. Neaton

    2016Circulation77 citations Open access

    Semantic Scholar

    Save

16. Systemic Inflammation, Coagulation, and Clinical Risk in the START Trial

    J. Baker, Shweta Sharma, B. Grund, Adam W. Rupert +10 more

    2017Open Forum Infectious Diseases74 citations Open access

    Semantic Scholar

    Save

17. Implementation of an Ebola virus disease vaccine clinical trial during the Ebola epidemic in Liberia: Design, procedures, and challenges

    S. B. Kennedy, J. Neaton, H. Lane, M. Kieh +9 more

    2016Clinical Trials74 citations Open access

    Semantic Scholar

    Save

18. Data monitoring committees: Promoting best practices to address emerging challenges

    T. Fleming, D. DeMets, M. Roe, J. Wittes +14 more

    2017Clinical Trials69 citations Open access

    Semantic Scholar

    Save

19. Association of Rivaroxaban With Thromboembolic Events in Patients With Heart Failure, Coronary Disease, and Sinus Rhythm: A Post Hoc Analysis of the COMMANDER HF Trial.

    B. Greenberg, J. Neaton, S. Anker, William M. Byra +11 more

    2019JAMA cardiology66 citations Open access

    Semantic Scholar

    Save

20. Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial

    M. Polizzotto, J. Nordwall, A. Babiker, A. Phillips +84 more

    2022The Lancet65 citations Open access

    Semantic Scholar

    Save

21. Responses to a neutralizing monoclonal antibody for hospitalized patients with COVID-19 according to baseline antibody and antigen levels: A randomized controlled trial

    J. Lundgren, B. Grund, C. Barkauskas, T. Holland +49 more

    2021Annals of Internal Medicine64 citations Open access

    Semantic Scholar

    Save

22. Inflammation Related Morbidity and Mortality Among HIV-Positive Adults: How Extensive Is It?

    Brian B. Hart, Anna D. Nordell, J. Okulicz, A. Palfreeman +6 more

    2017Journal of Acquired Immune Deficiency Syndromes59 citations Open access

    Semantic Scholar

    Save

23. End-stage Renal Disease in African-American and White Men

    M. Klag, P. Whelton, B. Randall, J. Neaton +2 more

    201656 citations

    Semantic Scholar

    Save

24. Design of a Randomized Controlled Trial for Ebola Virus Disease Medical Countermeasures: PREVAIL II, the Ebola MCM Study.

    Lori E. Dodd, M. Proschan, Jacqueline Neuhaus, J. Koopmeiners +5 more

    2016Journal of Infectious Diseases52 citations Open access

    Semantic Scholar

    Save

25. Randomized Trial of Vaccines for Zaire Ebola Virus Disease.

    M. Kieh, L. Richert, A. Beavogui, B. Grund +32 more

    2022New England Journal of Medicine50 citations Open access

    Semantic Scholar

    Save

26. High-Density Lipoprotein Subclasses and Noncardiovascular, Noncancer Chronic Inflammatory-Related Events Versus Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis

    D. Duprez, J. Otvos, R. Tracy, K. Feingold +7 more

    2015Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease49 citations Open access

    Semantic Scholar

    Save

27. The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19

    Angela J. Rogers, D. Wentworth, A. Phillips, K. Shaw-Saliba +36 more

    2022Annals of Internal Medicine42 citations Open access

    Semantic Scholar

    Save

28. Baseline cardiovascular risk in the INSIGHT Strategic Timing of AntiRetroviral Treatment trial

    E. Soliman, Shweta Sharma, K. Arastéh, D. Wohl +7 more

    2015HIV Medicine37 citations Open access

    Semantic Scholar

    Save

29. Long-Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection

    J. Lundgren, A. Babiker, Shweta Sharma, B. Grund +67 more

    2023NEJM Evidence36 citations Open access

    Semantic Scholar

    Save

30. Which HIV-Infected Adults with High CD4 T-Cells Benefit the Most from Immediate Treatment? A Post-Hoc Subgroup Analysis of the START Trial

    J. Molina, B. Grund, F. Gordin, I. Williams +12 more

    2018The Lancet HIV35 citations Open access

    Semantic Scholar

    Save

31. Analysis of an ordinal endpoint for use in evaluating treatments for severe influenza requiring hospitalization

    Ross L Peterson, D. Vock, J. Powers, S. Emery +5 more

    2017Clinical Trials33 citations Open access

    Semantic Scholar

    Save

32. Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3)

    Daniel D. Murray, A. Babiker, J. Baker, C. Barkauskas +24 more

    2021Clinical Trials32 citations Open access

    Semantic Scholar

    Save

33. Characterization of Ebola Virus–Associated Eye Disease

    Allen O. Eghrari, R. Bishop, R. Ross, Bionca Davis +24 more

    2021JAMA Network Open30 citations Open access

    Semantic Scholar

    Save

34. Incomplete ART adherence is associated with higher inflammation in individuals who achieved virologic suppression in the START study

    J. Castillo-Mancilla, A. Phillips, J. Neaton, Jacqueline Neuhaus +9 more

    2019Journal of the International AIDS Society28 citations Open access

    Semantic Scholar

    Save

35. RAGE has potential pathogenetic and prognostic value in nonintubated hospitalized patients with COVID-19

    K. Wick, L. Siegel, J. Neaton, C. Oldmixon +5 more

    2022JCI Insight25 citations Open access

    Semantic Scholar

    Save

36. Serious Non-AIDS Conditions in HIV: Benefit of Early ART

    J. Lundgren, Á. Borges, J. Neaton

    2018Current HIV/AIDS Reports24 citations

    Semantic Scholar

    Save

37. Investigation of Efavirenz Discontinuation in Multi-ethnic Populations of HIV-positive Individuals by Genetic Analysis

    N. Cummins, Jacqueline Neuhaus, H. Chu, J. Neaton +9 more

    2015EBioMedicine24 citations Open access

    Semantic Scholar

    Save

38. Randomized controlled trial of a self-administered five-day antiseptic bundle versus usual disinfectant soap showers for preoperative eradication of Staphylococcus aureus colonization

    S. Kline, J. Neaton, R. Lynfield, P. Ferrieri +7 more

    2018Infection control and hospital epidemiology23 citations

    Semantic Scholar

    Save

39. A Pilot Randomized Trial of Oral Magnesium Supplementation on Supraventricular Arrhythmias

    P. Lutsey, Lin Y. Chen, Anne A. Eaton, Melanie A. Jaeb +3 more

    2017bioRxiv23 citations Open access

    Semantic Scholar

    Save

40. The per-protocol effect of immediate vs. deferred ART initiation in the START randomized trial

    S. Lodi, Shweta Sharma, J. Lundgren, A. Phillips +9 more

    2016AIDS (London)23 citations Open access

    Semantic Scholar

    Save

41. INSIGHT FLU005: An Anti-Influenza Virus Hyperimmune Intravenous Immunoglobulin Pilot Study.

    R. Davey, N. Markowitz, J. Beigel, D. Wentworth +43 more

    2016Journal of Infectious Diseases23 citations Open access

    Semantic Scholar

    Save

42. Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscape

    P. Phillips, C. Mitnick, J. Neaton, Payam Nahid +2 more

    2019PLoS Medicine22 citations Open access

    Semantic Scholar

    Save

43. Association of Suboptimal Antiretroviral Therapy Adherence With Inflammation in Virologically Suppressed Individuals Enrolled in the SMART Study

    J. Castillo-Mancilla, A. Phillips, J. Neaton, Jacqueline Neuhaus +7 more

    2017Open Forum Infectious Diseases20 citations Open access

    Semantic Scholar

    Save

44. Risk Factors for Low CD4+ Count Recovery Despite Viral Suppression among Participants Initiating Antiretroviral Treatment with CD4+ Counts > 500 cells/mm3: Findings from the Strategic Timing of AntiRetroviral Treatment (START) Trial

    J. Boatman, J. Baker, S. Emery, H. Furrer +4 more

    2019Journal of Acquired Immune Deficiency Syndromes19 citations Open access

    Semantic Scholar

    Save

45. The Effect of Interrupted/Deferred Antiretroviral Therapy on Disease Risk: A SMART and START Combined Analysis

    Á. Borges, Jacqueline Neuhaus, Shweta Sharma, J. Neaton +5 more

    2018Journal of Infectious Diseases19 citations Open access

    Semantic Scholar

    Save

46. Natriuretic Peptide-Based Inclusion Criteria in a Heart Failure Clinical Trial: Insights From COMMANDER HF.

    J. Cunningham, J. Ferreira, H. Deng, S. Anker +11 more

    2020JACC. Heart failure18 citations Open access

    Semantic Scholar

    Save

47. Comparison of an ordinal endpoint to time-to-event, longitudinal, and binary endpoints for use in evaluating treatments for severe influenza requiring hospitalization

    Ross L Peterson, D. Vock, A. Babiker, J. Powers +4 more

    2019Contemporary Clinical Trials Communications18 citations Open access

    Semantic Scholar

    Save

48. What motivates adults to accept influenza vaccine? An assessment of incentives, ease of access, messaging, and sources of information using a discrete choice experiment.

    Kimberly E. Bonner, S. Chyderiotis, J. Sicsic, J. Mueller +5 more

    2023SSM: Population Health17 citations Open access

    Semantic Scholar

    Save

49. Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries

    Moses Badio, E. Lhomme, M. Kieh, A. Beavogui +22 more

    2020Trials17 citations Open access

    Semantic Scholar

    Save

50. The Benefit of Immediate Compared to Deferred ART on CD4+ Cell Count Recovery in Early HIV Infection

    Shweta Sharma, Katherine E. Schlusser, P. de la Torre, G. Tambussi +5 more

    2019AIDS (London)17 citations Open access

    Semantic Scholar

    Save